The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date
Win Min Oo,1,2 Christopher Little,3 Vicky Duong,1 David J Hunter1 1Rheumatology Department, Royal North Shore Hospital, and Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; 2Department of Physical Medicine and Rehab...
Saved in:
Main Authors: | Oo WM (Author), Little C (Author), Duong V (Author), Hunter DJ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
by: O. A. Shavlovskaya, et al.
Published: (2023) -
DMOADs and DMARDs in the treatment of patients with joint and spine diseases
by: O. A. Shavlovskaya
Published: (2024) -
Brodalumab in psoriasis: evidence to date and clinical potential
by: Amy C Foulkes, et al.
Published: (2019) -
Guselkumab for the treatment of psoriasis - evidence to date
by: Miguel Nogueira, et al.
Published: (2019) -
Venetoclax: evidence to date and clinical potential
by: Luis Miguel Juárez-Salcedo, et al.
Published: (2019)